| Item Type | Name |
|
Concept
|
Sepsis
|
|
Academic Article
|
Adenosine deaminase inhibition attenuates microvascular dysfunction and improves survival in sepsis.
|
|
Academic Article
|
Steroids for septic shock: back from the dead? (Pro).
|
|
Academic Article
|
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
|
|
Academic Article
|
New treatment strategies for severe sepsis and septic shock.
|
|
Academic Article
|
Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
|
|
Academic Article
|
A campaign worth joining: improving outcome in severe sepsis and septic shock using the Surviving Sepsis Campaign guidelines.
|
|
Academic Article
|
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study.
|
|
Academic Article
|
Roger C. Bone, MD and the evolving paradigms of sepsis.
|
|
Academic Article
|
Systemic steroids in severe sepsis and septic shock.
|
|
Academic Article
|
Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?
|
|
Academic Article
|
The New Sepsis Definitions: Implications for Critical Care Practitioners.
|
|
Academic Article
|
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
|
|
Academic Article
|
Prognostic factors in sepsis: the cold facts.
|
|
Academic Article
|
Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men.
|
|
Academic Article
|
Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.
|
|
Academic Article
|
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
|
|
Academic Article
|
Bacteremia during bronchoalveolar lavage.
|
|
Academic Article
|
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.
|
|
Academic Article
|
Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
|
|
Academic Article
|
Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
|
|
Academic Article
|
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
|
|
Academic Article
|
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
|
|
Academic Article
|
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.
|
|
Academic Article
|
Sepsis: a new hypothesis for pathogenesis of the disease process.
|
|
Academic Article
|
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
|
|
Academic Article
|
The relation of pneumothorax and other air leaks to mortality in the acute respiratory distress syndrome.
|
|
Academic Article
|
Therapeutic use of antithrombin concentrate in sepsis.
|
|
Academic Article
|
Nitric oxide in the pathogenesis of sepsis.
|
|
Academic Article
|
E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators.
|
|
Academic Article
|
Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations.
|
|
Academic Article
|
Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock.
|
|
Academic Article
|
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.
|
|
Academic Article
|
Impact of End-Stage Renal Disease and Acute Kidney Injury on ICU Outcomes in Patients With Sepsis.
|
|
Academic Article
|
Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.
|
|
Academic Article
|
To SIRS With Love-An Open Letter.
|
|
Academic Article
|
The new sepsis consensus definitions: the good, the bad and the ugly.
|
|
Academic Article
|
The characteristics and impact of source of infection on sepsis-related ICU outcomes.
|
|
Academic Article
|
Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.
|
|
Academic Article
|
Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.
|
|
Academic Article
|
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.
|
|
Academic Article
|
Physician agreement on the diagnosis of sepsis in the intensive care unit: estimation of concordance and analysis of underlying factors in a multicenter cohort.
|
|
Academic Article
|
Balanced Crystalloids Versus Saline in Critically Ill Adults: A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis.
|